Transcenta Holding-B (02617): The Stock Exchange grants listing approval for the implementation of full circulation of H shares.

Zhitong Finance APP News, TransThera-B (02617) announced that the Stock Exchange has granted approval (Listing Approval) for the listing and trading of 44,971,100 H shares (Converted H Shares) converted from 44,971,100 unlisted shares (Conversion) held by 10 shareholders of the Company (Participating Shareholders). The Stock Exchange granted the Listing Approval on October 30, 2026.